Skip to main content

Sheng Li, PhD

Los Angeles, CA
United States

University of Southern California

Dr. Sheng Li is an Associate Professor in the Department of Biochemistry and Molecular Medicine, with a secondary appointment in the Department of Translational Genomics, at the Keck School of Medicine, University of Southern California (USC). She is the Program Co-Leader of Epigenetic Regulation in Cancer (ERC) at the USC NCI-designated Norris Comprehensive Cancer Center. Dr. Li received her PhD in Computational Biology from Cornell University in 2014, where she focused on the epigenome dynamics of leukemia relapse. Following her PhD, she served as an Instructor of Bioinformatics at Weill Cornell Medicine. In 2016, Dr. Li joined the Jackson Laboratory for Genomic Medicine and was promoted to Associate Professor in 2022.

In 2024, her lab transitioned to the USC Keck School of Medicine. Dr. Li leads a research program centered on understanding the impact of somatic mutations and aging on blood cancer initiation by identifying critical epigenetic aberrations that disrupt gene expression regulating hematopoiesis. Her work leverages multi-omics and integrative data mining to study how age-related inflammation shapes the evolutionary trajectories of mutant hematopoietic stem cells in leukemogenesis. The long-term goal of her research is to identify novel therapeutics to mitigate leukemogenesis and extend human health span and life span. Dr. Li recevied NextGen Star Award from American Association for Cancer Research and Maximizing Investigators' Research Award from NIH National Institute of General Medical Sciences.

Program Name(s)
Career Development Program
Dr. Li